Cargando…

USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K

Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting with the inactivation of tumour suppressors and subsequent development of activating mutations in proto‐oncogenes, such as members of the PI3K or MAPK families. Cells undergoing transformation have to adjus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieto‐Garcia, Cristian, Hartmann, Oliver, Reissland, Michaela, Braun, Fabian, Bozkurt, Süleyman, Pahor, Nikolett, Fuss, Carmina, Schirbel, Andreas, Schülein‐Völk, Christina, Buchberger, Alexander, Calzado Canale, Marco A., Rosenfeldt, Mathias, Dikic, Ivan, Münch, Christian, Diefenbacher, Markus E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441007/ https://www.ncbi.nlm.nih.gov/pubmed/35364627 http://dx.doi.org/10.1002/1878-0261.13217

Ejemplares similares

Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2020)

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy
por: Fischer, Thomas, et al.
Publicado: (2022)

USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
por: Maier, Carina R., et al.
Publicado: (2023)

Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease
por: Hartmann, Oliver, et al.
Publicado: (2021)

Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
por: Saei, Azad, et al.
Publicado: (2018)

Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity
por: Gersch, Malte, et al.
Publicado: (2019)

Identification of recurrent USP48 and BRAF mutations in Cushing’s disease
por: Chen, Jianhua, et al.
Publicado: (2018)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25
por: Valero, Rebeca, et al.
Publicado: (2001)

USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization
por: Wei, Ying, et al.
Publicado: (2021)

Author Correction: Identification of recurrent USP48 and BRAF mutations in Cushing’s disease
por: Chen, Jianhua, et al.
Publicado: (2023)

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
por: Toth, Rachel K., et al.
Publicado: (2022)

Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway
por: Potu, Harish, et al.
Publicado: (2014)

RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival
por: Novak, Rostislav, et al.
Publicado: (2022)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells
por: Li, Junjun, et al.
Publicado: (2023)

Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide
por: Gerstmeier, Julia, et al.
Publicado: (2021)

Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth
por: Zhang, Lei, et al.
Publicado: (2015)

Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity
por: Peng, Jin, et al.
Publicado: (2022)

LUBAC determines chemotherapy resistance in squamous cell lung cancer
por: Ruiz, E. Josue, et al.
Publicado: (2019)

MON-525 Cardiovascular Status in Chronic Hypoparathyroidism: A Prospective Single-Center Analysis in 143 Patients
por: Fuss, Carmina, et al.
Publicado: (2019)

Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)

Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling
por: Bernhard, Sara Vanessa, et al.
Publicado: (2021)

Global mitochondrial protein import proteomics reveal distinct regulation by translation and translocation machinery
por: Schäfer, Jasmin Adriana, et al.
Publicado: (2022)

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
por: Ruiz, E Josue, et al.
Publicado: (2021)

Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis
por: Lv, Xiao, et al.
Publicado: (2018)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
por: Detomas, Mario, et al.
Publicado: (2021)

SENP1-mediated deSUMOylation of USP28 regulated HIF-1α accumulation and activation during hypoxia response
por: Du, Shi-chun, et al.
Publicado: (2019)

USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1
por: Chen, Leifeng, et al.
Publicado: (2021)

The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells
por: Wang, Jiewei, et al.
Publicado: (2021)

Copper is required for oncogenic BRAF signaling and tumorigenesis
por: Brady, Donita C., et al.
Publicado: (2014)

Targeting Oncogenic BRAF: Past, Present, and Future
por: Zaman, Aubhishek, et al.
Publicado: (2019)

Oncogenic BRAF Alterations and Their Role in Brain Tumors
por: Behling, Felix, et al.
Publicado: (2019)

Acetylation-dependent regulation of BRAF oncogenic function
por: Dai, Xiangpeng, et al.
Publicado: (2022)

LGG-28. NOVEL BRAF INTRAGENIC DELETION IN A GLIOMA: A CASE REPORT OF A PEDIATRIC PATIENT
por: Flores, Valerie Cruz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lkef1n0bhhglm6to7dtj5rsjqe